Related Experiment Video
Updated: May 17, 2025
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Sensitivity of Various Indicators in a Mouse Sensitive Skin Model Treatment with 4-tert-Butylcyclohexanol and
Xueting Tang1,2,3, Xueer Wang2,3, Yarui Zhang2,3
1School of Public Health, Southern Medical University, Guangzhou 510515, China.
Abstract:
The etiopathogenesis and treatment response of sensitive skin remain poorly understood. We used 4-tert-butylcyclohexanol (4-TBLH) and 1% pimecrolimus ointment to treat sensitive skin in mice models constructed using tape stripping, propylene glycol, and capsaicin. This study aimed to further investigate the sensitivity and responsiveness of this sensitive mouse skin model. Sensitivity and responsiveness were assessed by measuring transepidermal water loss (TEWL), skin hydration, skin flakes, vascular dilatation, itching, stinging, and histological changes, including mast cell, lymphocyte, and granulocyte infiltration, tumor necrosis factor-α (TNF-α) expression, and transient receptor potential vanilloid 1 receptor (TRPV1) expression. The application of 4-TBLH and pimecrolimus revealed distinct responses in skin sensitivity indicators, including TEWL, capillary dilation, and mass cell activity, depending on the treatment timing and substance used. The prophylactic and therapeutic applications of 4-TBLH revealed distinct responses in skin sensitivity indicators, including skin flakes, TEWL, itching, stinging, epidermal thickness, mast cell activity, TNF-α, and TRPV1 expression. The prophylactic and therapeutic applications of pimecrolimus ointment revealed distinct responses in skin sensitivity indicators, including skin flakes, skin water content, itching, epidermal thickness, mast cell activity, CD45, CD11b, TNF-α, and TRPV1 expression. The mouse sensitive skin model demonstrates robust sensitivity and responsiveness to different treatment factors, and the model can be applied to the development of prophylactic and therapeutic medications for sensitive skin.
Insights
This study validates a mouse model for sensitive skin, showing distinct responses to 4-tert-butylcyclohexanol (4-TBLH) and pimecrolimus. This model aids in developing new sensitive skin treatments.
Area of Science:
- Dermatology
- Pharmacology
- Immunology
Background:
- Sensitive skin's causes and treatment responses are not fully understood.
- Developing reliable models is crucial for sensitive skin research.
Purpose of the Study:
- To investigate the sensitivity and responsiveness of a novel mouse model for sensitive skin.
- To evaluate the effects of 4-tert-butylcyclohexanol (4-TBLH) and pimecrolimus on this model.
Main Methods:
- Induced sensitive skin in mice using tape stripping, propylene glycol, and capsaicin.
- Assessed sensitivity via transepidermal water loss (TEWL), hydration, and histological analysis.
- Measured inflammatory markers like TNF-α and TRPV1 expression, and immune cell infiltration.
Main Results:
- Both 4-TBLH and pimecrolimus showed distinct effects on TEWL, capillary dilation, and mast cell activity.
- Prophylactic and therapeutic applications yielded different responses in skin flakes, itching, stinging, and inflammatory markers.
- The model demonstrated sensitivity to treatment timing and substance, with measurable changes in epidermal thickness and immune markers.
Conclusions:
- The developed mouse model exhibits significant sensitivity and responsiveness to various treatments.
- This model is suitable for evaluating prophylactic and therapeutic agents for sensitive skin conditions.
